Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Avibactam is a non-β-lactam β-lactamase inhibitor that has been approved in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and nosocomial pneumonia, including ventilator-associated pneumonia. In Europe, ceftazidime-avib...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Das, Shampa, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J., Newell, Paul, Melnick, David, Critchley, Ian A., Stone, Gregory G., Nichols, Wright W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2019
Aiheet:
Minireview
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437548/
https://ncbi.nlm.nih.gov/pubmed/30670413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02187-18
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia